Gilead Sciences Inc logo

GILD - Gilead Sciences Inc News Story

$60.21 -0.3  -0.6%

Last Trade - 9:00pm

Sector
Healthcare
Size
Large Cap
Market Cap £58.65bn
Enterprise Value £62.74bn
Revenue £17.13bn
Position in Universe 131st / 6436

BUZZ-NanoViricides Inc: Rises on selecting COVID-19 drug candidate

Wed 16th September, 2020 12:57pm
** Antiviral drug developer's shares  NNVC.A  rise 6.4% to
$4.8 premarket 
    ** Late on Tuesday, co said it has selected a drug candidate
for the treatment of COVID-19  urn:newsml:reuters.com:*:nEQ4TQgHka
    ** NV-CoV-1 is designed to attack the virus particles
themselves, and possibly would also attack infected cells - NNVC
    ** Says its drug candidate, NV-CoV-1-R, has Gilead Sciences
Inc's  GILD.O  remdesivir encapsulated inside the core
    ** Up to Tuesday's close, stock had risen ~81% YTD 

 (Reporting by Dania Nadeem in Bengaluru)
 ((Dania.Nadeem@thomsonreuters.com; within U.S. +1 646 223 8780,
outside U.S. +91 80 6182 3463;))
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.